Time-regulated Transcripts with the Potential to Modulate Human Pluripotent Stem Cell-derived Cardiomyocyte Differentiation

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2022 Sep 2

PMID 36056380

Authors

Juan J A M Munoz

Rafael Dariolli

Caio Mateus da Silva

Elida A Neri

Iuri C Valadao

Lauro Thiago Turaca

Vanessa M Lima

Mariana Lombardi Peres de Carvalho

Mariliza R Velho

Eric A Sobie

Jose E Krieger

Affiliations

Soon will be listed here.

Abstract

Background: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are a promising disease model, even though hiPSC-CMs cultured for extended periods display an undifferentiated transcriptional landscape. MiRNA-target gene interactions contribute to fine-tuning the genetic program governing cardiac maturation and may uncover critical pathways to be targeted.

Methods: We analyzed a hiPSC-CM public dataset to identify time-regulated miRNA-target gene interactions based on three logical steps of filtering. We validated this process in silico using 14 human and mouse public datasets, and further confirmed the findings by sampling seven time points over a 30-day protocol with a hiPSC-CM clone developed in our laboratory. We then added miRNA mimics from the top eight miRNAs candidates in three cell clones in two different moments of cardiac specification and maturation to assess their impact on differentiation characteristics including proliferation, sarcomere structure, contractility, and calcium handling.

Results: We uncovered 324 interactions among 29 differentially expressed genes and 51 miRNAs from 20,543 transcripts through 120 days of hiPSC-CM differentiation and selected 16 genes and 25 miRNAs based on the inverse pattern of expression (Pearson R-values < - 0.5) and consistency in different datasets. We validated 16 inverse interactions among eight genes and 12 miRNAs (Person R-values < - 0.5) during hiPSC-CMs differentiation and used miRNAs mimics to verify proliferation, structural and functional features related to maturation. We also demonstrated that miR-124 affects Ca handling altering features associated with hiPSC-CMs maturation.

Conclusion: We uncovered time-regulated transcripts influencing pathways affecting cardiac differentiation/maturation axis and showed that the top-scoring miRNAs indeed affect primarily structural features highlighting their role in the hiPSC-CM maturation.

Citing Articles

Extended voltage imaging in cardiomyocytes with a triplet state quencher-stabilized silicon rhodamine.

Martinez K, Gerstner N, Yang S, Miller E Bioorg Med Chem Lett. 2024; 109:129842.

PMID: 38844174 PMC: 11648968. DOI: 10.1016/j.bmcl.2024.129842.

Engineering the maturation of stem cell-derived cardiomyocytes.

Hong Y, Zhao Y, Li H, Yang Y, Chen M, Wang X Front Bioeng Biotechnol. 2023; 11:1155052.

PMID: 37034258 PMC: 10073467. DOI: 10.3389/fbioe.2023.1155052.

References

Sharma A, Zhang Y, Buikema J, Serpooshan V, Chirikian O, Kosaric N . Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation. Sci Rep. 2018; 8(1):6618. PMC: 5920079. DOI: 10.1038/s41598-018-24954-3. View

Maas R, Lee S, Harakalova M, Snijders Blok C, Goodyer W, Hjortnaes J . Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes. STAR Protoc. 2021; 2(1):100334. PMC: 7881265. DOI: 10.1016/j.xpro.2021.100334. View

Lima I, Lilian Dos Santos Schiavinato J, Paulino Leite S, Sastre D, Bezerra H, Sangiorgi B . High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation. Stem Cell Res Ther. 2019; 10(1):202. PMC: 6615276. DOI: 10.1186/s13287-019-1318-6. View

Kuppusamy K, Jones D, Sperber H, Madan A, Fischer K, Rodriguez M . Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc Natl Acad Sci U S A. 2015; 112(21):E2785-94. PMC: 4450404. DOI: 10.1073/pnas.1424042112. View

Ronaldson-Bouchard K, Ma S, Yeager K, Chen T, Song L, Sirabella D . Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018; 556(7700):239-243. PMC: 5895513. DOI: 10.1038/s41586-018-0016-3. View

Dariolli R, Campana C, Gutierrez A, Sobie E . and Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic "COVID-19 Cardiomyocyte". Front Physiol. 2021; 12:624185. PMC: 7925402. DOI: 10.3389/fphys.2021.624185. View

Kleinsorge M, Cyganek L . Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes. STAR Protoc. 2020; 1(1):100026. PMC: 7580117. DOI: 10.1016/j.xpro.2020.100026. View

Babiarz J, Ravon M, Sridhar S, Ravindran P, Swanson B, Bitter H . Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev. 2011; 21(11):1956-65. PMC: 4048009. DOI: 10.1089/scd.2011.0357. View

Nicolescu R, Al-Khawaga S, Minassian B, Hussain K . Diabetes Mellitus in a Patient With Lafora Disease: Possible Links With Pancreatic β-Cell Dysfunction and Insulin Resistance. Front Pediatr. 2019; 6:424. PMC: 6343460. DOI: 10.3389/fped.2018.00424. View

10.

Churko J, Garg P, Treutlein B, Venkatasubramanian M, Wu H, Lee J . Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. Nat Commun. 2018; 9(1):4906. PMC: 6249224. DOI: 10.1038/s41467-018-07333-4. View

11.

Garate X, La Greca A, Neiman G, Bluguermann C, Santin Velazque N, Moro L . Identification of the miRNAome of early mesoderm progenitor cells and cardiomyocytes derived from human pluripotent stem cells. Sci Rep. 2018; 8(1):8072. PMC: 5966391. DOI: 10.1038/s41598-018-26156-3. View

12.

Xu F, Yang J, Shang J, Lan F, Li M, Shi L . MicroRNA-302d promotes the proliferation of human pluripotent stem cell-derived cardiomyocytes by inhibiting in the Hippo pathway. Clin Sci (Lond). 2019; 133(13):1387-1399. DOI: 10.1042/CS20190099. View

13.

Ford S, Chandra M . The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform. J Physiol. 2012; 590(23):6047-63. PMC: 3530116. DOI: 10.1113/jphysiol.2012.240085. View

14.

Homan T, Delanoe-Ayari H, Meli A, Cazorla O, Gergely C, Mejat A . MorphoScript: a dedicated analysis to assess the morphology and contractile structures of cardiomyocytes derived from stem cells. Bioinformatics. 2021; 37(22):4209-4215. DOI: 10.1093/bioinformatics/btab400. View

15.

Karbassi E, Fenix A, Marchiano S, Muraoka N, Nakamura K, Yang X . Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol. 2020; 17(6):341-359. PMC: 7239749. DOI: 10.1038/s41569-019-0331-x. View

16.

Burridge P, Keller G, Gold J, Wu J . Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 2012; 10(1):16-28. PMC: 3255078. DOI: 10.1016/j.stem.2011.12.013. View

17.

Scalzo S, Afonso M, da Fonseca Jr N, Jesus I, Alves A, Mendonca C . Dense optical flow software to quantify cellular contractility. Cell Rep Methods. 2022; 1(4):100044. PMC: 9017166. DOI: 10.1016/j.crmeth.2021.100044. View

18.

Ding H, Zhang H, Wang J, Zhou J, Shen F, Ji R . miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8. Mol Med Rep. 2021; 23(5). PMC: 7974325. DOI: 10.3892/mmr.2021.11961. View

19.

Lin Y, Zou J . Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells in Fully Chemically Defined Conditions. STAR Protoc. 2020; 1(1). PMC: 7392178. DOI: 10.1016/j.xpro.2020.100015. View

20.

Kolanowski T, Antos C, Guan K . Making human cardiomyocytes up to date: Derivation, maturation state and perspectives. Int J Cardiol. 2017; 241:379-386. DOI: 10.1016/j.ijcard.2017.03.099. View